Conference Presentations

List of Conference Presentations

This page lists conference presentations by our physicians and researchers, reflecting clinical experience and research activities in the field of cancer immunotherapy and personalized medicine.

Clinical Outcomes of Cancer Immunotherapy in Our Clinic and a Case Report of Effective Immunotherapy in Endometrial Cancer

Amane Sasada, Kazue Miyamoto, Minako Abe, Hiroyuki Abe
The 30th International Congress of Personalized Medicine, December 17, 2025, Tokyo, Japan

Empowering Health Through Lifestyle Medicine

Minako Abe
The 29th International Congress of Personalized Medicine, November 17, 2024, Tokyo, Japan

Evaluation of Treatment Response Assessment Tests in Cancer Immune Cell Therapy

Amane Sasada, Yukie Saeki, Minako Abe, Hiroyuki Abe
The 29th International Congress of Personalized Medicine, November 17, 2024, Tokyo, Japan

Forest Aromatherapy’s Effects on Immune Cell Cytokine Activity: A Pilot Study

Minako Abe, Satomi Kaminaga, Yukie Saeki, Hiroyuki Abe
The 29th International Congress of Personalized Medicine, November 17, 2024, Tokyo, Japan

Lifestyle Coaching in Patients with Cancer: Case Study

Minako Abe, Hiroyuki Abe
The 28th International Congress of Personalized Medicine, October 9, 2023, Tokyo, Japan

Effect of Coenzyme Q10 on Long-Term Heart Failure Induced by Postoperative Herceptin Therapy in Right Breast Cancer (Luminal B)

Hiroyuki Abe, Minako Abe, Amane Sasada
The 28th International Congress of Personalized Medicine, October 9, 2023, Tokyo, Japan

Dendritic Cell and Natural Killer Cell stability for immunotherapy after long-term cryopreservation

Emiko Fukushima, Minako Abe, Ayaka Nagami, Yasuha Nakaseko, Hazuki Yamajo, Hitomi Chibana, Hiroyuki Abe
The 27th International Congress of Personalized Medicine, Nobember 6, 2022, Tokyo, Japan

Efficacy of Combined Immunotherapy for Invasive Ductal Carcinoma (IDC) with Tumor Fever

Amane Sasada, Minako Abe, Hiroyuki Abe, Takayuki Azuma
The 27th International Congress of Personalized Medicine, Nobember 6, 2022, Tokyo, Japan

Personalized Medicine in Cancer Treatment and Chronic Pain Management: Our Clinic’s Approach to Regenerative Medicine

Amane Sasada
The 26th International Congress of Personalized Medicine, November 28, 2021, Tokyo, Japan

Circulating tumor cells (CTC) and Cell-Free DNA (cfDNA) : Liquid biopsy for cancer diagnostics

Ayaka Nakamura, Minako Abe, Yukie Saeki, Fumiko Kono, Yasuha Ono, Hiroyuki Abe
The 26th International Congress of Personalized Medicine, November 28, 2021, Tokyo, Japan

Prediction and Prevention of Alzheimer’s Disease Using Autoantibodies

Hiroyuki Abe, Amane Sasada, Minako Abe
The 26th International Congress of Personalized Medicine, November 28, 2021, Tokyo, Japan

Evaluation of the Utility of cfDNA Quantification in Monitoring Cancer Immunotherapy

Ayumi Morokuma, Fumika Kohno, Yukie Saeki, Minako Abe, Hiroyuki Abe
The 25th International Congress of Personalized Medicine, October 20, 2019, Tokyo, Japan

The Role of NK Cells in Breast Cancer

Ben-ning Zhang, Hiroyuki Abe, Midori Tada, Zhibo Zhang, Katsuro Igarashi
The 25th International Congress of Personalized Medicine, October 20, 2019, Tokyo, Japan

Personalized polyvalent DC vaccine pulsed with various long overlapped peptide antigens -A pilot study in patients with intractable non-small cell cancer (NSLC)

Hiroyuki Abe, Minako Abe
International Symposium on Immune Diversity and Cancer Therapy Kobe 2017, January 26–28, 2017, Kobe, Japan
Biomarkers & Immuno-oncology World Congress 2017, May 2–4, 2017, Philadelphia, USA
The 23rd International Congress of Personalized Medicine, October 28, 2017, Tokyo, Japan

Analysis of DNA Methylation in Cancer-Related Genes of Cell-Free DNA in the Peripheral Blood of Patients with Biliary Tract Cancer

Yukie Saeki, Fumika Kohno, Akane Nagazato, Yoshimori Ishihara, Minako Abe, Hiroyuki Abe
The 22nd International Congress of Personalized Medicine, October 29, 2016, Tokyo, Japan

A case of advance ovarian cancer efficiently treated with combination of immunotherapies and surgical and chemotherapies

Amane Sasada, Hiroyuki Abe
The 22nd International Congress of Personalized Medicine, October 29, 2016, Tokyo, Japan

A Novel Cancer Vaccine; ABeVax® Multi-peptide Dendritic Cell Vaccine

Hiroyuki Abe
VII All-Russian conference with the international participation, September 28, 2016, Moscow, Russia

How Cancer Vaccine Works for Cancers

Hiroyuki Abe
VII All-Russian conference with the international participation, September 26, 2016, Moscow, Russia

A case of elderly patient with lung cancer efficiently treated with Dendritic Cell Immunotherapy

Amane Sasada, Shigeki Tabata, Minako Abe, Hiroyuki Abe
The 20th International Congress of Personalized Medicine, May 24, 2015, Tokyo, Japan

Indications and Limitations of Dendritic Cell Vaccines

Hiroyuki Abe, Shigeki Tabata, Amane Sasada, Megumi Takagi, Teruyo Yamashita, Ariko Yamauchi, Minako Abe
The 6th Annual Meeting of Japanese Society of Medical Health Science, November 23, 2013, Tokyo, Japan

Analysis of Five Cases Showing Complete Disappearance of Cancer-Related Gene Expression After Dendritic Cell Vaccine Therapy

Shigeki Tabata, Teruyo Yamashita, Ariko Yamauchi, Hiroyuki Abe
The 16th International Congress of Personalized Medicine, May 25, 2013, Miyazaki, Japan

Extracorporeal Membrance Oxygenation for Bridge to Decision and to Recovery

Shigeki Tabata, Hitoshi Hirose, Nicholas C. Cavarocchi, James T. Diehl, Hiroyuki Abe
The 16th International Congress of Personalized Medicine, May 25, 2013, Miyazaki, Japan

Personalized Medicine and Cancer Treatment

Hiroyuki Abe
42nd Orthomolecular Medicine Today, April 26 – 28, 2013, Toronto, Canada

Anti-Tumor Effect of Dendritic Cell-based Vaccine for Inoperable Prostatic Cancer

Hiroyuki Abe, Shinichiro Akiyama, Ben-ning Zhang
The 12th International Symposium on Dendritic Cells. October 7-11, 2012, Daegu, Korea

Evaluation of Dendritic Cell Vaccine Therapy for Advanced or Recurrent Pancreatic Cancer

Shinichiro Akiyama, Teruyo Yamashita, Ariko Yamauchi, Touko Shimamoto, Hiroshi Nimura, Hiroyuki Abe
The 14th International Congress of Personalized Medicine, June 2, 2012, Tochigi, Japan